2026-02-25
基因疗法研发商
医药研发/制造
化学&生物药
DSC Investment;
DSC Investment;
Yuanta Investment;
Yuanta Investment;
ACVC Partners;
KDB Silicon Valley;
Woori Venture Partners;
Korea Investment Partners;
LoftyRock Investment;
Dayli Partners;
Top Harvest Capital;
Stic Ventures;
Kiwoom Investment;
SV Investment
2025-12-18
癌症治疗药物研发商
医药研发/制造
化学&生物药
2025-10-28
肿瘤颠覆性疗法开发商
医药研发/制造
化学&生物药
2024-12-27
靶向蛋白降解领域新药研发商
医药研发/制造
化学&生物药
Yuanta Investment;
Yuanta Investment;
Quantum FA;
Quantum FA;
Korea Investment Partners;
Korea Development Bank;
KB Investment;
DSC Investment
2024-06-06
人工智能病理辅助诊断平台
AI+辅助诊断
医疗信息化
2024-02-28
眼科药物开发商
医药研发/制造
化学&生物药
2024-01-23
基因疗法研发商
医药研发/制造
化学&生物药
KIMCO;
KIMCO;
Dong-A ST;
Dong-A ST;
K2 Investment Partners;
Terra VC;
LoftyRock Investment;
Pathway Partners;
ACVC;
Mirae Asset Venture Investments;
KDB Silicon Valley;
Timefolio Asset Management;
IMM Investment;
KB Investment;
Dayli Partners;
Woori Venture Partners;
Korea Investment Partners;
Sequoia Capital;
Eli Lilly
2023-04-25
免疫疗法开发商
医药研发/制造
化学&生物药
Bill and Melinda Gates Foundation;
Bill and Melinda Gates Foundation;
AXA IM Alts;
AXA IM Alts;
Seventure Partners;
QUAD;
辉瑞;
Revelation Partners;
Atlantic Neptune;
Reimagined Ventures;
PEAK6;
Hambro Perks;
K2 HealthVentures;
Skyviews Life Science;
AMR Action Fund;
Korea Investment Partners;
Korea Investment＆Securities;
PureTech Health
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
GlobeNewswire2026-03-10
PRNewswire2026-03-10
PRNewswire2026-03-10
400-9696-311 转1
400-9696-311 转2
400-9696-311 转3
400-9696-311 转4
川公网安备51019002008863号
本网站未发布麻醉药品、精神药品、医疗用毒性药品、放射性药品、戒毒药品和医疗机构制剂的产品信息
“坚决打赢禁毒人民战争”专栏 法律法规 | 美、墨、欧盟管制品种
友情链接: 摩熵医药 摩熵医药企业版 摩熵化学MolAid 晓材Matmole 摩熵医学MedXYZ 载体质粒 觅健肿瘤互助 动脉网 药物百科 中国医疗人才网 医药招商网
